Immediate Impact
2 from Science/Nature 52 standout
Citing Papers
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout
Inorganic nanomaterials with rapid clearance for biomedical applications
2021 Standout
Works of S.B. Kaye being referenced
Brivanib (BMS-582664) in advanced solid tumors (AST): Results of a phase II randomized discontinuation trial (RDT).
2011
Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)
1994
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S.B. Kaye | 145 | 258 | 53 | 127 | 13 | 406 | |
| J.T. Soper | 112 | 162 | 97 | 123 | 14 | 412 | |
| Eileen Keenan | 106 | 210 | 99 | 117 | 17 | 436 | |
| Laura Scaltriti | 76 | 220 | 122 | 169 | 10 | 437 | |
| D. Mirchandani | 125 | 161 | 43 | 55 | 15 | 366 | |
| Vincent Hansen | 47 | 113 | 88 | 95 | 17 | 350 | |
| Irene Grimani | 81 | 166 | 44 | 102 | 11 | 357 | |
| Steven Roffers | 39 | 172 | 83 | 77 | 12 | 363 | |
| Leslie D. Boucher | 86 | 232 | 42 | 24 | 13 | 373 | |
| Joseph Haas | 93 | 99 | 78 | 108 | 17 | 430 | |
| Heather Foster | 99 | 98 | 70 | 226 | 11 | 413 |
All Works
Loading papers...